← Back to headlines
Axsome Therapeutics Highlights Auvelity Momentum and Sales Push at Oppenheimer Conference
Axsome Therapeutics discussed the strong performance of its drug Auvelity, its strategy for a 600-representative sales force, and an upcoming PDUFA date at the Oppenheimer Conference.
26 Feb, 02:10 — 26 Feb, 02:10
ℹOnly 1 source covers this story
Read at source (1 outlet)
Related Stories
DOTr, LTFRB: Fuel subsidy being prepared as oil price hikes loom
just now
Blockade of a key global oil route raises energy prices: Fuel, food, and electricity could become more expensive in BiH as well
11m ago
Strait of Hormuz: 70% drop in shipping – Dozens of tankers "blocked"
12m ago
The 60th ITB Berlin tourism fair begins - with Angola in the main role. Poland among the exhibitors
15m ago